Epicardio Simulation™ is celebrating more than 6,000 individual users from around the world in 2022. A total of 72,324 hours were spent on Epicardio apps, with more that 18 hours of total average daily usage. Overall Epicardio usage more than doubled since 2021.
About Vassilios Hurmusiadis
Posts by Vassilios Hurmusiadis:
Epicardio wins prestigious Global Cooperation grant award by Innovate UK, aiming to facilitate Epicardio’s entry into the North American medical education market. As part of this project we will start trials at leading medical schools in USA, Canada and Mexico.
Bienvenido a Epicardio Simulation™
Hemos diseñado esta herramienta inteligente para ayudarle a mejorar su comprensión y maestría del sistema circulatorio humano. Hemos preparado tutoriales interactivos que cubren los casos clínicos más comunes y también los mas difíciles, como las arrítmias, los marcapasos y EF Cardiaca.
Epicardio releases the Temporary Cardiac Pacing App – 3D TCP Training Simulator
Developed for health care professionals, medical and nursing students who are interested in a deeper understanding of temporary cardiac pacing procedures. This independently validated app employs interactive real-time 3D exploration into Temporary Cardiac Pacing to aid learning. The app is available on the App Store and on Google Play. All text is available in English and German.
Epicardio releases the “Atrial Fibrillation” app – 3D AFib training simulator.
Developed for healthcare professionals, medical and nursing students who are interested in a deeper understanding of Atrial Fibrillation. This independently validated app employs interactive real-time 3D exploration into Atrial Fibrillation to aid learning. Available on the App Store and on Google Play in English, German and Mandarin.